Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Prostate Cancer

  Free Subscription


10.07.2017

1 Acta Radiol
4 Anticancer Res
1 BJU Int
2 BMC Cancer
1 BMC Urol
1 Cancer
1 Int J Cancer
1 J Urol
3 Nat Rev Urol
1 Oncogene
2 Oncol Rep
1 PLoS One
1 Prostate
1 Radiology
1 Urol Int


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Radiol

  1. BOESEN L, Norgaard N, Logager V, Balslev I, et al
    Multiparametric MRI in men with clinical suspicion of prostate cancer undergoing repeat biopsy: a prospective comparison with clinical findings and histopathology.
    Acta Radiol. 2017 Jan 1:284185117718400. doi: 10.1177/0284185117718400.
    PubMed     Text format     Abstract available


    Anticancer Res

  2. WINTERS B, Brown L, Coleman I, Nguyen H, et al
    Inhibition of ERG Activity in Patient-derived Prostate Cancer Xenografts by YK-4-279.
    Anticancer Res. 2017;37:3385-3396.
    PubMed     Text format     Abstract available

  3. DETTI B, D'Angelillo RM, Ingrosso G, Olmetto E, et al
    Combining Abiraterone and Radiotherapy in Prostate Cancer Patients Who Progressed During Abiraterone Therapy.
    Anticancer Res. 2017;37:3717-3722.
    PubMed     Text format     Abstract available

  4. MIYAZAWA Y, Takahiro S, Yoshitaka S, Nomura M, et al
    Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab.
    Anticancer Res. 2017;37:3667-3671.
    PubMed     Text format     Abstract available

  5. OZGUR E, Celik AI, Darendeliler E, Gezer U, et al
    PCA3 Silencing Sensitizes Prostate Cancer Cells to Enzalutamide-mediated Androgen Receptor Blockade.
    Anticancer Res. 2017;37:3631-3637.
    PubMed     Text format     Abstract available


    BJU Int

  6. LANGLEY SEM, Soares R, Uribe J, Uribe-Lewis S, et al
    Long-term oncological outcomes and toxicity in 597 men </=60 years of age at time of low dose rate brachytherapy for localised prostate cancer.
    BJU Int. 2017 Jul 3. doi: 10.1111/bju.13946.
    PubMed     Text format     Abstract available


    BMC Cancer

  7. KEALL P, Nguyen DT, O'Brien R, Booth J, et al
    Stereotactic prostate adaptive radiotherapy utilising kilovoltage intrafraction monitoring: the TROG 15.01 SPARK trial.
    BMC Cancer. 2017;17:180.
    PubMed     Text format     Abstract available

  8. GRANT DJ, Chen Z, Howard LE, Wiggins E, et al
    UDP-glucuronosyltransferases and biochemical recurrence in prostate cancer progression.
    BMC Cancer. 2017;17:463.
    PubMed     Text format     Abstract available


    BMC Urol

  9. PEABODY JW, DeMaria LM, Tamondong-Lachica D, Florentino J, et al
    Impact of a protein-based assay that predicts prostate cancer aggressiveness on urologists' recommendations for active treatment or active surveillance: a randomized clinical utility trial.
    BMC Urol. 2017;17:51.
    PubMed     Text format     Abstract available


    Cancer

  10. HURWITZ LM, Cullen J, Kim DJ, Elsamanoudi S, et al
    Longitudinal regret after treatment for low- and intermediate-risk prostate cancer.
    Cancer. 2017 Jul 5. doi: 10.1002/cncr.30841.
    PubMed     Text format     Abstract available


    Int J Cancer

  11. SCHECHER S, Walter B, Falkenstein M, Macher-Goeppinger S, et al
    Cyclin K dependent regulation of Aurora B affects apoptosis and proliferation by induction of mitotic catastrophe in prostate cancer.
    Int J Cancer. 2017 Jul 3. doi: 10.1002/ijc.30864.
    PubMed     Text format     Abstract available


    J Urol

  12. BHINDI B, Karnes RJ, Rangel LJ, Mason RJ, et al
    Independent Validation of the American Joint Committee on Cancer 8th Edition Prostate Cancer Staging Classification.
    J Urol. 2017 Jun 29. pii: S0022-5347(17)77027-9. doi: 10.1016/j.juro.2017.
    PubMed     Text format     Abstract available


    Nat Rev Urol

  13. THOMA C
    Prostate cancer: Epigenetic AR regulation.
    Nat Rev Urol. 2017 Jul 4. doi: 10.1038/nrurol.2017.
    PubMed     Text format    

  14. STONE L
    Prostate cancer: Mechanisms of cancer metabolism: mTORC1 mediates AMD1.
    Nat Rev Urol. 2017 Jul 4. doi: 10.1038/nrurol.2017.
    PubMed     Text format    

  15. GRAHAM MK, Meeker A
    Telomeres and telomerase in prostate cancer development and therapy.
    Nat Rev Urol. 2017 Jul 4. doi: 10.1038/nrurol.2017.
    PubMed     Text format     Abstract available


    Oncogene

  16. VALENTINO A, Calarco A, Di Salle A, Finicelli M, et al
    Deregulation of MicroRNAs mediated control of carnitine cycle in prostate cancer: molecular basis and pathophysiological consequences.
    Oncogene. 2017 Jul 3. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    Oncol Rep

  17. ZHOU Y, Ji Z, Yan W, Zhou Z, et al
    Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1.
    Oncol Rep. 2017 Jun 29. doi: 10.3892/or.2017.5768.
    PubMed     Text format     Abstract available

  18. XUAN Q, Zhong X, Li W, Mo Z, et al
    CtBP2 is associated with angiogenesis and regulates the apoptosis of prostate cancer cells.
    Oncol Rep. 2017 Jun 28. doi: 10.3892/or.2017.5763.
    PubMed     Text format     Abstract available


    PLoS One

  19. ROY A, Ramalinga M, Kim OJ, Chijioke J, et al
    Multiple roles of RARRES1 in prostate cancer: Autophagy induction and angiogenesis inhibition.
    PLoS One. 2017;12:e0180344.
    PubMed     Text format     Abstract available


    Prostate

  20. CHEN H, Na R, Packiam VT, Conran CA, et al
    Reclassification of prostate cancer risk using sequentially identified SNPs: Results from the REDUCE trial.
    Prostate. 2017 Jul 2. doi: 10.1002/pros.23369.
    PubMed     Text format     Abstract available


    Radiology

  21. JAMSHIDI N, Margolis DJ, Raman S, Huang J, et al
    Multiregional Radiogenomic Assessment of Prostate Microenvironments with Multiparametric MR Imaging and DNA Whole-Exome Sequencing of Prostate Glands with Adenocarcinoma.
    Radiology. 2017 Apr 28:162827. doi: 10.1148/radiol.2017162827.
    PubMed     Text format     Abstract available


    Urol Int

  22. FAHMY O, Khairul-Asri MG, Hadi SHSM, Gakis G, et al
    The Role of Radical Prostatectomy and Radiotherapy in Treatment of Locally Advanced Prostate Cancer: A Systematic Review and Meta-Analysis.
    Urol Int. 2017 Jul 4. doi: 10.1159/000478789.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: